Analyst Group company information, Employees & Contact Information

Comment on Zenith’s New Solar Acquisitions and Strategic Update Analyst Group

Interview with Freetrailer’s CEO Nicolai Frisch Erichsen Analyst Group

Interview with GreenMobility’s CEO Kasper Gjedsted Analyst Group

Interview with Eurobattery Minerals CEO Roberto Garcia Martinez Analyst Group

Comment on STENOCARE’s Q3-report 2025 Analyst Group

Comment on Zenith’s New Solar and Battery Storage Acquisition Analyst Group

Analyst Group Comment on Zenith’s Acquisition of Solar Energy Project Analyst Group

Comment on Zenith’s Accepted ICC-2 Annulment Application Analyst Group

Interview with CEO of Zenith Energy, Andrea Cattaneo, regarding the ongoing listing process in Sweden Analyst Group

Interview with BPC Instruments CEO Jing Liu Analyst Group

Comment on Irisity’s fully guaranteed rights issue of SEK 26m Analyst Group

Interview with Irisity’s interim CEO Gustav Zaar Analyst Group

Zenith Energy Analyst Group

Analyst Group Comment on Zenith’s Final Submission in ICSID Arbitration Analyst Group

Comment on Irisity’s Contract Wins and R&D Consolidation Analyst Group

Comment on PEG’s H1 Report for 2025 Analyst Group

Comment on Zenith’s Results in ICC-2 against ETAP Analyst Group

Comment on Genetic Analysis Q2-report Report 2025 Analyst Group

Analyst Group Comment on Zenith’s Secured Subscription and Guarantee Commitments Analyst Group

Comment on Genetic Analysis Launch of GA-map® MHI GutHealth Reagent kit Analyst Group

Comment on Pharma Equity Group’s regulatory approval to initiate Phase II clinical trial for RNX-011 Analyst Group

Comment on HydrogenPro’s Q2-report 2025 Analyst Group

Interview with Zenith Energy’s CEO Andrea Cattaneo Analyst Group

Comment on Irisity’s Q2 Report for 2025 Analyst Group

Comment on HydrogenPro’s partnership with Thermax to Indigenise Alkaline Water Electrolysis Solution for Large Scale Hydrogen Projects Analyst Group

Comment on STENOCARE’s Q2-report 2025 Analyst Group

Comment on Genetic Analysis Directed Share Issue of NOK 12.8m Analyst Group

Interview with Boreo’s CEO Kari Nerg Analyst Group

Comment on Irisity’s Q1 Report for 2025 Analyst Group

Analyst Group Initiates Equity Research Coverage and Comments on Genetic Analysis Q4-24 report Analyst Group

Interview with Ensurge Micropower’s CEO Lars Eikeland Analyst Group

Interview with Talenom’s CEO Otto-Pekka Huhtala Analyst Group

Interview with Fodelia’s CEO Riikka Wulff Analyst Group

Comment on Björn Borg’s Year-End Report for 2024 Analyst Group

Interview with F-Secure’s CFO Sari Somerkallio Analyst Group

Interview with Marimekko’s CFO Elina Anckar Analyst Group

Interview with MT Højgaard Holding’s CFO Dennis Nørgaard Analyst Group

Interview with Brdr. A&O Johansen’s CFO Per Toelstang Analyst Group

Interview with Nexcom’s CEO Rolf Gordon Adamson Analyst Group

Comment on Eevia Health’s Initiated Divestment of Assets Related to Berry-Extract Manufacturing Analyst Group

Interview with Trifork’s Group Investment Director Frederik Svanholm Analyst Group

Vow Analyst Group

Interview with Tulikivi’s CEO Heikki Vauhkonen Analyst Group

Interview with MPC Container Ships’ Co-CEO and CFO Moritz Fuhrmann Analyst Group

Interview with Icelandic Salmon’s CEO Björn Hembre Analyst Group

Interview with Kreate Group’s CEO Timo Vikström Analyst Group

Interview with Glaston’s CEO Toni Laaksonen Analyst Group

Interview with Aspo’s CEO Rolf Jansson Analyst Group

Interview with Betolar’s CEO Tuija Kalpala Analyst Group

Interview with Lamor’s CEO Johan Grön Analyst Group

Interview with LeadDesk’s CEO Olli Nokso-Koivisto Analyst Group

Interview with Soiltech’s CFO Tove Vestlie Analyst Group

Interview with Paxman’s CEO Richard Paxman Analyst Group

Interview with Nexstim’s CEO Mikko Karvinen Analyst Group

Comment on Eevia’s reorganized distribution in North America and New Order Analyst Group

Interview with Navamedic’s CEO Kathrine Gamborg Andreassen Analyst Group

Interview with Ocean Sun’s CEO Kristian Tørvold Analyst Group

Interview with Magnora’s CEO Erik Sneve Analyst Group

Interview with Vistin Pharma’s CEO Magnus Tolleshaug and CFO Alexander Karlsen Analyst Group

Björn Borg Q2-24 Analyst Group

Interview with Apetit’s CEO Esa Mäki Analyst Group

Analyst Group Comments on Björn Borgs Year-End Report for 2023 Analyst Group

Interview with Verkkokauppa.com’s Head of Investor Relations Marja Mäkinen Analyst Group

Interview with Huddly’s CFO Abhijit Saha Banik Analyst Group

Interview with Itera’s CFO Bent Hammer Analyst Group

Interview with Optomed’s CEO Juho Himberg Analyst Group

Interview with Pharma Equity Group’s CEO Thomas Kaas Selsø Analyst Group

Interview with ContextVision’s CEO Gerald Pötzsch Analyst Group

Interview with Mintra’s CEO Kevin Short Analyst Group

Interview with BPC Instruments CEO Jing Liu Analyst Group

Björn Borg Analyst Group

Interview with Harboes Bryggeri’s CEO Søren Malling Analyst Group

Interview with Northgolds CEO Mitchell J. Vanderydt Analyst Group

Interview with Cambi’s CEO Eirik Fadnes Analyst Group

Interim Update of Cindrigo Analysis Analyst Group

Interview with Omda’s CFO Einar Bonnevie Analyst Group

Nekkar Analyst Group

Intervju med Brdr. A & O Johansens CFO Per Toelstang Analyst Group

Intervju med Newbury Pharmaceuticals VD Lars Minor Analyst Group

Trophy Games Analyst Group

Intervju med AcouSorts VD Torsten Freltoft Analyst Group